Incannex Healthcare (IXHL) Net Equity Issued and Repurchased (2023 - 2026)
Incannex Healthcare (IXHL) posted Net Equity Issued and Repurchased of $7.0 million for Q1 2026, up 216.57% sequentially from $2.2 million in Q4 2025.
Incannex Healthcare (IXHL) Net Equity Issued and Repurchased (2023 - 2026) Analysis & Trends
Incannex Healthcare has reported Net Equity Issued and Repurchased for 3 years, with the latest figure at $7.0 million in Q1 2026.
- Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $7.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $114.5 million (changed N/A YoY) and the FY2025 annual result came in at $48.3 million, changed N/A from the prior year.
- Net Equity Issued and Repurchased improved to $7.0 million in Q1 2026 per IXHL's latest filing, from $2.2 million in the prior quarter.
- Over five years, Net Equity Issued and Repurchased peaked at $69.5 million in Q3 2025 and troughed at -$73000.0 in Q1 2023.
- A 3-year average of $19.1 million and a median of $4.6 million in 2025 frame the typical range for Net Equity Issued and Repurchased.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | - |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 700,000.00 |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 84.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Incannex Healthcare | 44.39 Mn | 44.39 Mn | - | 6.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.96 Mn |
| Mar 31, 2026 | 6.96 Mn |
| Dec 31, 2025 | 2.20 Mn |
| Dec 31, 2025 | 2.20 Mn |
| Sep 30, 2025 | 69.47 Mn |
| Sep 30, 2025 | 69.47 Mn |
| Jun 30, 2025 | 35.90 Mn |
| Jun 30, 2025 | 35.90 Mn |
| Jun 30, 2023 | -32,000.00 |
| Jun 30, 2023 | -32,000.00 |
| Mar 31, 2023 | -73,000.00 |
| Mar 31, 2023 | -73,000.00 |